PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $52,000 | -45.3% | 12,321 | -18.4% | 0.00% | -25.0% |
| Q3 2018 | $95,000 | -23.4% | 15,093 | -2.1% | 0.00% | -20.0% |
| Q2 2018 | $124,000 | +21.6% | 15,420 | +13.0% | 0.01% | +25.0% |
| Q1 2018 | $102,000 | +47.8% | 13,645 | +17.2% | 0.00% | +33.3% |
| Q4 2017 | $69,000 | -28.9% | 11,644 | -18.1% | 0.00% | -25.0% |
| Q2 2017 | $97,000 | -24.2% | 14,223 | +5.1% | 0.00% | -33.3% |
| Q1 2017 | $128,000 | – | 13,535 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|